Navigation Links
Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund
Date:3/11/2009

Bill Ensures Greater Prevention, Treatment and Care Services for People around the World Affected by AIDS, Tuberculosis and Malaria

WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Late yesterday the U.S. Senate voted to pass H.R. 1105, the Omnibus Appropriations bill for fiscal year 2009. The bill, passed by the House of Representatives last week, contains an appropriation of $900 million for the Global Fund to Fight AIDS, Tuberculosis and Malaria.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080925/DC35212LOGO)

"In these challenging economic times, the United States Congress has demonstrated real leadership," said Friends of the Global Fight Executive Director, Natasha Bilimoria. "Global Fund financing fights HIV/AIDS, tuberculosis and malaria around the world, thanks to the dedicated support of members of Congress including Senators Richard Durbin (D-IL), Patrick Leahy (D-VT), and Arlen Specter (R-PA), Representatives David Obey (D-WI), Nita Lowey (D-NY), Barbara Lee (D-CA), and Jesse Jackson, Jr. (D-IL), as well as Speaker Nancy Pelosi (D-CA)."

At the end of 2008, Global Fund-supported programs had averted more than 3.5 million deaths by providing AIDS treatment for two million people, anti-tuberculosis treatment for 4.6 million people and 70 million insecticide-treated bed nets for the prevention of malaria. To date, the Global Fund has approved $15 billion in funding.

In the seven years since its inception, the Global Fund has grown capacity for health programs in developing countries to meet the challenges presented by HIV/AIDS, tuberculosis and malaria within their borders. At its last meeting in India, the Global Fund Board of Directors approved the largest round of financing in the history of the organization (more than double any previous round), with 94 new grants worth $2.75 billion over two years. With the $900 million appropriated, the Global Fund is much closer to meeting the demand for financing. Nevertheless, a shortfall of $350 million remains, delaying a number of approved grants.

"The Global Fund has demonstrated unprecedented need, and the U.S. has responded with unprecedented funding," continued Bilimoria. "We look forward to working with the Administration and the Congress to expand upon this longstanding support for the Global Fund."

FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA

Friends of the Global Fight works to educate, engage and mobilize American decision makers to support the Global Fund and the fight to end the worldwide burden of AIDS, tuberculosis and malaria. For more information about Friends of the Global Fight, visit www.theglobalfight.org.

THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

The Global Fund is a unique global public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV/AIDS, tuberculosis and malaria. This partnership between governments, civil society, the private sector and affected communities represents a new approach to international health financing. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts dealing with the three diseases. For more information about the Global Fund, visit www.theglobalfund.org.


'/>"/>
SOURCE Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. An Incubator or Cataract Surgery for $25? Heart Bypass Surgery for $2,000? See How it Works at Extremely Affordable Health Innovations at The World Health Care Congress, April 14-16, Washington, DC
2. Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco
3. Workers from Across Nation Lobby Congress to Get Economy Back on Track with Employee Free Choice Act
4. House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill
5. Dr. Arun Sreekumar lectures on new candidate biomarker at Annual EAU Congress
6. Canada to host diabetes mega-congress
7. Education and progress at the 24th Annual EAU Congress in Stockholm
8. House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products
9. Oral and Maxillofacial Surgeons Applaud Congresswoman McCarthys Resolution Raising Awareness of Preventable Facial Trauma During Sports Activities
10. Congressman Jerry McNearney (D-Calif.) becomes 76th Co-Sponsor of H.R. 22
11. Congress Can Deliver Historic Victory for Children and Americas Health By Granting FDA Authority Over Tobacco Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PITTSBURGH, PA (PRWEB) , ... December 09, 2016 , ... ... treatments," said an inventor from Winchester, Va. "I thought that if the nebulizer had ... their treatments rather than fearing them." , He developed the patent-pending NEBY to avoid ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Medical Center has been recognized for adherence to the highest standards of ... medical accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... -- Research and Markets has announced the addition of ... Type, Application, Usability - Forecast to 2025" report to their ... , , ... to grow at a CAGR of around 3.2% from 2015 to ... include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in ...
(Date:12/8/2016)...   TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...
Breaking Medicine Technology: